甲基胺与安慰剂治疗晚期癌症患者的疲劳:MePFAC随机对照试验
Patrick Stone1, Ollie Minton2, Alison Richardson3
1Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London, London, UK.
Health technology assessment (Winchester, England)
|August 4, 2025
概括
在接受息治疗的晚期癌症患者中,甲基酸并没有显著降低与癌症相关的疲劳. 发现该药物安全且耐受性良好,但对这一群体不建议进行进一步的试验.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 药理学 药理学是指药理学的学科.
背景情况:
- 以前的元分析表明,甲基酸对与癌症相关的疲劳有潜在的疗效.
- 与癌症相关的疲劳是接受息治疗的晚期癌症患者的常见和衰弱症状.
研究的目的:
- 为了评估甲基酸盐与安慰剂相比在减少与癌症相关的疲劳方面的临床有效性.
- 评估甲基酸在该患者群体中的安全性和耐受性.
主要方法:
- 进行了III期,并行组,随机,双盲,安慰剂受控试验.
- 招募了接受息治疗的晚期癌症和疲劳的成年人.
- 主要结局是6周的慢性疾病治疗功能评估 - 疲劳量表测量疲劳严重程度.
主要成果:
- 在甲基胺和安慰剂组之间没有观察到疲劳严重程度的统计或临床显著差异.
- 甲基酸盐在整个研究期间的疲劳得分中显示了名义上的统计学上显著的改善,但没有达到临床上重要的最小差异.
- 在生活质量或大多数症状领域中没有发现显著差异,尽管抑郁症得分在名义上被甲基化物减少.
结论:
- 甲基酸在接受息治疗的晚期癌症患者中,没有证明它能有效降低与癌症相关的疲劳.
- 这种药物被发现是安全的,并且在这个患者群体中耐受良好.
- 不建议对这种特定的适应症和人群进行进一步的甲基酸试验.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
444
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
444
Parkinson's Disease: Treatment
380
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
380
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


